CAMBRIDGE, Mass., Nov. 24, 2021 /PRNewswire/ -- Akebia
Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company
with the purpose to better the lives of people impacted by kidney
disease, today announced that John P.
Butler, Chief Executive Officer, and David A. Spellman, Chief Financial Officer, will
participate in the following investor conferences:
Piper Sandler 33rd
Annual Virtual Healthcare Conference
November 29 – December 2,
2021
John Butler will
participate in a virtual fireside chat, which will be available on
the conference site prior to the virtual event.
4th Annual Evercore ISI HealthCONx
Conference
November 30 - December
2, 2021
John Butler
will participate in a virtual fireside chat, which will be
presented on Tuesday, November 30 at
4:45 on the conference site.
Where applicable, webcasts of Akebia's fireside chats will be
made available on the Investors section of the Company's website at
https://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. The Company
was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
Mcarrasco@akebia.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-participation-in-upcoming-investor-conferences-301431123.html
SOURCE Akebia Therapeutics